NCT06169930Completed
Development and Validation of a Survival Prediction Model for Esophageal Cancer Patients After Esophagectomy
Development and Validation of A Overall Survival Prediction Model for Esophageal Squamous Cell Carcinoma: A Novel pN Classification
Source: ClinicalTrials.gov · Last updated 14 Dec 2023
Brief summary (registry, in English)
In this retrospective study, we analyzed data from the Sichuan Cancer Hospital \& Institute Esophageal Cancer Case Management Database (SCH-ECCM Database) from January 2010 to December 2017. Our study focused on examining the clinicopathological characteristics, lymph node removal at each station, and treatment details of patients with esophageal squamous cell carcinoma (ESCC) who underwent esophagectomy. Using this data, we developed a prediction model for OS by considering a combination of clinical characteristics and details of lymphadenectomy variables.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 2957 (actual)
- First submitted
- 3 Dec 2023
- Start date
- 1 Dec 2023
- Primary completion date
- 1 Dec 2023
- Lead sponsor
- Yongtao Han
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT06169930
What you commit to
- Study type: Observational
- Participants enrolled: 2957
- From 1 Dec 2023 to the primary completion date, 1 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- R1/R2 resection was performed indicating incomplete tumor removal,
- they underwent preoperative neoadjuvant therapy
Other
- pathology confirmed a non-squamous cell carcinoma,
- the tumor was located outside of the thoracic region,
- evidence of distant tumor metastasis was observed, or
Who the study is looking for
- Patients underwent esophagectomy at our hospital.
Age in the registry: 18 years to 90 years · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sichuan Cancer Hospital and Research Institute Coordinator of this site? Confirm its status | Chengdu | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.